The Centers for Disease Control and Prevention (CDC) remains leaderless as of Wednesday, with no acting director stepping up after Jay Bhattacharya had to step down. This comes amid mounting tensions within the Trump administration over Robert F. Kennedy Jr.’s anti-vaccine policies.

Kennedy’s controversial moves include rolling back vaccine recommendations, cancelling funding for mRNA technology, and firing expert advisors in favour of hand-picked anti-vax allies. His actions have sparked outrage, with the potential to harm Republican prospects in upcoming midterm elections.

Notably, Kennedy has faced criticism during several measles outbreaks, spreading misinformation about the vaccine while advocating unproven treatments. The CDC’s response has been notably muted amid his leadership.

The 210-day deadline for a Senate-confirmed appointment looms, raising questions over who will steer public health policy in America’s ongoing battle against infectious diseases.

With no official acting director and an administration struggling to contain Kennedy’s divisive agenda, the future of public health remains uncertain. Only time—and perhaps a change in political winds—will determine if this gap is filled with competence or further chaos.